The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine to counter any future flu pandemic.

The FDA's approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback.

The decision caps a seven-month review that included a rare refusal to consider the shot at all.

Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Aug. 5, 2026 approved a new mRNA-based flu vaccine. (Melissa Phillip/AP) After months of regulatory questioning, the ...

Moderna (NasdaqGS:MRNA) received FDA approval for updated Spikevax and mNEXSPIKE COVID-19 vaccines tailored to the latest ...

(CNN) — For older adults, the flu vaccine could look a little different this year. Last week, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people ...

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

On August 5, 2026, Moderna announced that the U.S. Food and Drug Administration (FDA) approved mFLUSIVA® (mRNA-1010), a seasonal influenza vaccine ...

Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology. On Thursday, vaccine maker Moderna ...

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. “Flu remains a significant public health ...